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Abstract
Background: Natural killer (NK) cells are cytotoxic lymphocytes that lack CD3 and express
variable levels of CD16, CD56 and CD57. In recent years NK cells have been categorised into two
major groups based on the level of CD56 expression. This phenotypic classification correlates with
functional activity as CD56bright NK cells are the major cytokine producing subset whereas CD56dim
NK cells exhibit greater cytotoxic activity. Previous studies have revealed a reduction in total NK
cell numbers in association with ageing and this study sought to determine the potential influence
of ageing on the number of NK cell subsets within peripheral blood.
Results: The number of NK (CD56+CD3-) cells within peripheral blood did not change with
increasing age. The number of CD56dim NK cells also remained stable with ageing. In contrast the
absolute number of CD56bright NK cells within peripheral blood declined by 48% with ageing from
a mean of 15.6/µl in individuals aged 20–40 years to 8.1/µl in those aged 60+ years (p = 0.0004).
Conclusion: The number of CD56bright NK cells within peripheral blood declines with age. As this
population plays a central role in cytokine secretion during the innate immune response this decline
may contribute to impaired immune regulation in elderly individuals
Background
Natural killer (NK) cells are a heterogenous group of large
granular lymphocytes derived from bone marrow precur-
sors which are phenotypically distinct from T and B lym-
phocytes. NK cells have been recognised to constitute up
to 10% of peripheral blood lymphocytes (PBMC) and are
also found in peripheral tissues including the peritoneal
cavity, placenta and liver [1,2]. NK cell activation is gov-
erned by a balance of signals through activatory and
inhibitory receptors [3] although activation in response to
downregulation of MHC class I molecules on the target
cell is a potent influence. NK cells represent the first line
of defence against virus-infected and neoplastic cells and
initiate cell lysis and cytokine production in the absence
of prior antigenic stimulation [1,2,4]. The potential role
of NK cells in the control of cancer has been suggested by
the observation of an inverse correlation between the NK
cell count and incidence of malignant disease in cohort
studies of humans with further support derived from
murine studies [5-7]. NK cell participation has been
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reported in the immune response to several viruses
including HIV, hepatitis B and C, but it may have particu-
lar relevance in host defence against herpes viridae [7-9].
The relevance of NK cells in the host defence against her-
pes viruses is best illustrated in the case of isolated NK cell
deficiency resulting in a range of systemic herpes viral
infections [10].
The NK cell phenotype is characterized by lack of expres-
sion of the CD3 complex together with variable expres-
sion of CD16, CD56 and CD57. CD56 is an integrin with
homotypic adhesion properties and in recent years studies
have demonstrated the existence of two NK cell subsets
based on the intensity of CD56 expression. These
CD56bright and CD56dim subsets are thought to differ in
their tissue homing properties due to differential patterns
of expression of chemokine receptors and adhesion mol-
ecules. CD56bright NK cells lack or express low levels of
CD16 and represent only 10% of circulating NK cells but
are the dominant NK cell subset within lymph nodes [11].
In contrast, the major CD56dim NK cell population has a
granular phenotype and exhibits more cytotoxic activity
than CD56bright NK cells. In addition this subset expresses
higher levels of CD16 and is thus more potent in anti-
body-directed cell cytotoxicity (ADCC). In contrast,
CD56bright NK cells are the primary source of immunoreg-
ulatory cytokines such as IL-10, IL-13 and GM-CSF follow-
ing antigen recognition with minimal production of these
molecules being observed from CD56dim NK cells [3]. This
cytokine response is likely to be critical in the activation of
the adaptive immune response by NK cells.
Ageing is associated with an increased mortality and mor-
bidity from infectious disease and cancer and this is at
least partly related to the development of immune senes-
cence. Previous reports have demonstrated alterations in
NK cell number and phenotype in association with age. In
this study we have extended these observations to enu-
merate NK cells with respect to the CD56bright  and
CD56dim subsets, and have correlated these findings with
age.
Results
Patient characteristics
The study population consisted of 115 individuals that
were divided into those aged 20–40 years (n = 25), 40–60
years (n = 23) and > 60 years (n = 67, mean age 79 years).
The absolute lymphocyte count was determined using an
automated Coulter full blood counter and expressed as
cells/µl of blood. The total NK population was expressed
both as an absolute number (µl/blood) and as a percent-
age of the lymphoid pool. CD56 expression on NK cells
was determined by staining cells with an anti-CD56 anti-
body conjugated to phycoerythrin followed by flow
cytometry. NK cells were separated into two subsets based
on the level of CD56 expression and cell numbers deter-
mined in a similar way (figure 1).
The effect of age on NK cell number: elderly individuals 
have a trend towards a greater proportion of NK cells 
within peripheral blood
The number of NK cells was determined for each age
cohort and compared as a function of ageing. A marked
variation in the number of NK cells was observed between
different donors. However, although there was a trend
towards a small increase in mean NK cell number with
ageing this did not reach statistical significance (195 cells/
µl for individuals aged 20–40 years; 206 cells/µl for
donors aged > 60 years) (figure 2). The total lymphocyte
count fell with age and analysis of NK cells as a percentage
of lymphocytes revealed a small increase with advancing
age (table 1). NK cells represent 9.3% of the peripheral
lymphocyte pool in donors aged 20–40 years which
increases to 11.2% in donors aged over 60 years.
The effect of age on CD56bright NK cell number: elderly 
individuals have a significantly lower number of CD56bright 
NK cells
The effect of age was analysed with respect to the number
of peripheral blood CD56bright NK cells using 3 colour
flow cytometric analysis. A progressive decrease is
observed with advancing age; 15.6 cells/µl detected in the
younger cohort aged 20–40 years falling to 8.1 cells/µl in
donors aged over 60 years (p = 0.0004) (figure 3) (table
2). CD56bright NK cells analysed as a percentage of the
peripheral blood lymphocytes also significantly decreases
with advancing age.
Identification of CD56bright and CD56dim NK cells Figure 1
Identification of CD56bright and CD56dim NK cells. 
Peripheral blood lymphocytes were stained with CD3, CD56 
and CD16 mABs and analysed. The CD3negative lymphocyte 
population was initially gated and then analysed for CD56 
and CD16 expression. Gates A and B allow enumeration of 
the CD56bright and CD56dim NK cell population respectively.
CD56
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The effect of age on peripheral blood NK cells Figure 2
The effect of age on peripheral blood NK cells. These graphs illustrate (a) the number of NK cells µl/blood and (b) the 
percentage of lymphocytes that NK cells represent within samples in each age group; 20–40(n = 25) 40–60(n = 23) and 60 + (n 
= 67). The mean values within each respective cohort group are marked. Statistical analysis was carried out as described in the 
Methods; p values between groups are displayed and results are summarised further in table 1.
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The effect of age on CD56dim NK cell number: cell number 
remains constant with age
The influence of age on peripheral blood CD56dim NK
cells revealed relatively consistent numbers at all ages. A
trend towards a slight increase in CD56dim NK cells µl/
blood was found between the 40–60 and 60+ year cohorts
although this did not reach statistical significance (figure
3). A non-significant increase in CD56dim NK cells as a
percentage of the peripheral blood lymphoid pool was
also observed with advancing age (table 2 , figure 4).
Discussion
The decline in immune function with increasing age is
termed immune senescence and leads to impaired
responses to vaccination, an increased incidence of
autoimmune disorders and increased morbidity and mor-
tality to infectious disease [12-15]. Immune senescence
has been attributed to a number of factors including
thymic involution and memory T cell accumulation
resulting in contraction of the T cell repertoire. More
recently, debate has focused on the role of innate cellular
immunity with regard to impaired immune function.
Remarque  et al. have reported that elderly individuals
with low NK numbers have a three-fold increased risk of
mortality in the first two years of follow up compared to
those with high NK cells [16]. Functional studies have
measured NK cell activity against the K562 tumour cell
line and demonstrate impaired NK cell cytotoxicity in eld-
erly donors [17]. Further evidence is derived from studies
on centenarians, regarded as a model example of healthy
ageing, who have been reported to have well preserved NK
cell cytotoxicity [18]. Our data shows that NK cell num-
bers are relatively stable with advancing age but as the
total peripheral blood lymphocyte count decreases there
is a small increase in the proportion of the lymphoid com-
partment occupied by NK cells.
Our findings demonstrate that the number of CD56bright
NK cells declines with advancing age which may have con-
siderable implications for NK cell function in the elderly
cohort. This decline was apparent across all three age
groups indicating a gradual decline with healthy ageing.
The CD56dim NK cell subset remains relatively constant
but occupies a greater portion of the peripheral blood
lymphoid pool with advancing age. Our findings are in
keeping with Krishnaraj (1997) who also reports a signif-
icant reduction in the proportion of CD56bright cells with
relative sparing of the CD56dim subset [19]. This contrasts
with Borrego et al. (1999) who reports an expansion in the
proportion in CD56dim cells but little change in CD56bright
NK cells [20]. Differences in the methodology employed
in these studies are likely to account for the variation in
results.
NK cell associated cytotoxic function is thought to be
mediated primarily through the CD56dim NK cell subset
whereas the CD56bright NK cells can be thought of prima-
rily as a cytokine producing subset. The CD56dim cell is
more cytotoxic than the CD56bright NK cell subset [21] and
the morphological appearance of CD56dim cells shows
greater granularity [1]. A substantial body of data indi-
cates that the CD56bright subpopulation plays a critical role
in the early innate immune response. CD56bright NK cells
have a higher proliferative capacity than CD56dim NK cells
Table 2: The effect of age on CD56bright and CD56dim NK cells
Age 20–40 40–60 60+
N = 25 23 67
CD56bright µl/blood (+/- SD) 15.64 (+/-12.8) 12.81 (+/-12) *** 8.13 (+/-7.9)****
CD56bright as % of lymphocytes (+/-SD) 0.76 (+/-0.6) 0.72 (+/-0.6) * 0.50 (+/-0.5) **
CD56dim µl/blood (+/-SD) 179.3 (+/-135.3) 174.8 (+/-135) 197.7(+/-180.3)
CD56dim as % of lymphocytes (+/-SD) 8.49 (+/-5.8) 9.86 (+/-7.0) 11.7 (+/-9.3)
Statistical analysis was carried out as described in the Methods; * p = 0.031 between the 40–60 and 60+ age groups, ** p = 0.012 between the 20–
40 and 60+ age groups. ***p = 0.03 between the 40–60 and 60+ age groups, ****p = 0.0004 between the 20–40 and 60+ age groups.
Table 1: The effect of age on NK cell number
Age(yrs) N = Mean NK cell µl/blood (+/- SD) Mean NK cells % of lymphocytes (+/-SD)
20–40 25 194.9 (+/- 140.4) 9.25 (+/- 6.1)
40–60 23 187.6 (+/- 144.5) 10.59 (+/- 7.5)
> 60 67 205.8 (+/- 184.0) 11.22 (+/- 9.1)
Statistical analysis was carried out as described in the Methods; no significant differences between groups were found.Immunity & Ageing 2006, 3:10 http://www.immunityageing.com/content/3/1/10
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The effect of age on peripheral blood CD56bright and CD56dim NK cell number Figure 3
The effect of age on peripheral blood CD56bright and CD56dim NK cell number. These graphs illustrate (a) the 
number of CD56dim NK cells µl/blood and (b) the percentage of CD56bright NK cells µl/blood within samples in each age group; 
20–40(n = 25) 40–60(n = 23) and 60 + (n = 67). The mean values within each respective cohort group are displayed. Statistical 
analysis was carried out as described in the Methods and p values between groups are shown. These results are summarised 
together with the percentage of the lymphoid pool occupied by CD56bright and CD56dim cells and are displayed in table 2.
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[22] and are also the primary source of NK cell-derived
cytokines including TNF-α, IFN-γ, IL-10, IL-13, and GM-
CSF [11]. NK cell culture with lipopolysaccharide-acti-
vated macrophages, providing an endogenous monokine
source, resulted in a greater than 6-fold IFN-y production
from CD56bright NK cells in comparison with CD56dim NK
cells [11].
The importance of NK cells in the priming of adaptive
immunity is becoming clearer in recent years and
CD56bright NK cells play an important role in the activa-
tion of dendritic cells [23]. A recent study found that
lipopolysaccharide cultured with immature dendritic cells
induced proliferation of peripheral blood NK cells
restricted to CD56bright NK cell subset which was also the
main source of IFN-γ associated with dendritic cell inter-
action [24]. CD56bright NK cells also interact with mono-
cytes in a reciprocal fashion thereby promoting
inflammation [25].
CD56 expression also determines the anatomical location
of the major NK cell subsets. CD56bright NK cells are the
predominant NK cell subset within lymphoid tissue and
inflammatory lesions and exhibit differential expression
of a range of chemokine receptors and adhesion mole-
cules including CD62L, CCR7 and CXCR3 [24]. The
CD56bright NK cell subset constitutively expresses high
affinity IL-2R and produces IFN-γ in response to picomo-
lar doses of IL-2 from T cells through interactions within
secondary lymphoid organs [11].
These observations suggest that a reduction in CD56bright
NK cells may contribute to the impairment in immunity
towards newly encountered foreign pathogens that is
associated with ageing. The role of NK cells in the initia-
tion of adaptive T and B cell responses [26] may be partic-
ularly impaired in elderly individuals due to lower
circulating numbers of the CD56bright NK cells.
Conclusion
We have shown that the number of CD56bright NK cells
within peripheral blood decreases with age. As this popu-
lation plays a critical role in the cytokine response of the
innate immune system these findings suggest that a
decline in CD56bright NK cell number may contribute to
the development of immune senescence.
Methods
Subjects
67 donors aged over 60 were contacted through the
'Thousand Elders', Centre of Applied Gerontology, Selly
Oak Hospital. Peripheral blood was acquired through
The percentage of total peripheral blood lymphocytes represented by CD56bright and CD56dim NK cells with advancing age Figure 4
The percentage of total peripheral blood lymphocytes represented by CD56bright and CD56dim NK cells with 
advancing age. This graph illustrates the percentage of the total peripheral blood lymphoid pool represented by CD56bright 
and CD56dim NK cell subsets. These results are also documented in tables 1 and 2.
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venepuncture into the following vacutainer tubes (BD
Vacutainer); Sodium Heparin, EDTA, and Clot activator
(silica coated, BD Haemoguard). Informed consent was
obtained from all donors under the South Birmingham
ethical committee protocol. Peripheral blood from a fur-
ther 48 individuals were acquired from the National
Blood Service, Blood Transfusion Services, Birmingham.
These samples were anonymous, such that only the sex
and age range between 5–10 years was provided. These
samples were kept in EDTA tubes (BD Vacutainer) and
collected on the same date of peripheral blood collection.
All blood samples were submitted to the Queen Elizabeth
Hospital Haematology lab for full blood count analysis
on the same date of collection (in EDTA tubes).
Isolation of peripheral blood mononuclear cells
Isolation of peripheral blood mononuclear cells
(PBMC's) from heparinized blood samples was achieved
through Ficoll-assisted (Lymphoprep, Axis Shield UK)
density gradient centrifugation. Cell washing was carried
out twice using RMPI media (RPMI 1640, GibcoBRL).
Cells were subsequently resuspended in 1 ml freezing
media (10% DMSO, 90% heat activated FCS). Aliquots of
cells were frozen down in 1 ml cryotubes at concentra-
tions of around 1–10 × 106 cells/ml. Cryotubes were
placed in a Nalgene Cryo Freezing container and stored at
immediately at -80°C. Isolation and freezing of PMBC's
was undertaken on the same day of blood collection. Iso-
lation of PBMC's used for functional work however were
resuspended in RPMI growth media.
Staining with monoclonal antibodies and FACS analysis
Frozen cells were thawed in waterbaths no longer than 1
min, and subsequently washed twice in MACS buffer.
Cells were incubated at 4°C for 25 minutes with CD3-
PC5 (Cyto-Stat Coulter Clone), CD56-PE (Dako Cytoma-
tion), CD16-FITC (Dako Cytomation). Cell populations
were analysed using Win MDI 2.8. following data collec-
tion using a Coulter XL flow cytometer.
Statistical analysis
Statistics were calculated using Graph Pad Prism4 soft-
ware. The Mann-Whitney U Test was employed to find
inter-group differences. Two-tailed p values were
employed, where a significant result was represented by p
= 0.05 or less.
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